Trial
NCT00590460
Antibody Conditioning Regimen For Allogeneic Donor Stem Cell Transplantation Of Patients With Fanconi Anemia
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Baylor College of Medicine
Collaborators
The Methodist Hospital Research Institute; Center for Cell and Gene Therapy, Baylor College of Medicine
Condition
Fanconi Anemia
Intervention
CAMPATH-1H
Why stopped
slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-24